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Abstract 
The hypothesis that mild hyperoxa l uri a is 
more important than hyperca l ci uri a in the 
pathogenesis of urolithiasis is re-examined in 
the light of new evidence. Small increments in 
urinary oxalate in the normal to high-normal 
range are much more critical than similar rises 
in urinary calcium for increasing the relative 
supersaturation of urine with respect to calcium 
oxalate, the oxalate/calcium ratio in urine, the 
total volume of calcium oxalate crystals 
excreted, the proportion of abnormally large 
crystals and aggregates of calcium oxalate and 
the severity of the disorder as defined by the 
recurrence rate of stone-formation. Data from 
the Arabian Peninsula, where the prevalence of 
calcium-containing stones is considerably higher 
than in the West, have shown that this occurs in 
spite of the almost complete absence of 
hyperca lei uri a. On the other hand, there is a 
strong association between stone-formation and 
the occurrence of mild hyperoxaluria. The life-
time expectancy of stone-formation in men from 
various countries is strongly correlated with 
the average daily excretion of oxalate in the 
urine of the normal men in these countries. 
This relationship extends to include patients 
with enteric and hereditary hyperoxaluria. 
There is no such relationship, however, between 
the life-time expectancy of stones and urinary 
calcium excretion in the same populations. 
Studies on the regulation of urinary 
oxalate indicate that it is largely controlled 
by the quantity of "free" dietary oxalate 
available for absorption in the lower intestine 
This can be calculated from the intakes of 
calcium and oxalate and the urinary excretion of 
calcium. 
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Introduction 
For over half a century, hypercalciuria has 
been considered by the majority of researchers 
in the kidney stone field to be the main risk 
factor for primary (idiopathic) and secondary 
calcium urol ithiasis (Flocks, 1939; Albright et 
al., 1953; Hodgkinson and Pyrah, 1958; Pak et 
al., 1975; Coe and Favus, 1980; Hal abe and 
Sutton, 1987). The main evidence cited in 
support of this hypothesis is that most we 11-
control led studies which have compared the 
urinary excretions of minerals by stone-formers 
and normals have shown that the patients tend to 
excrete more calcium although there is 
invariably a large degree of overlap between the 
two groups. This overlap is so considerable 
that, once allowance is made for the true 
prevalence of urinary stone-formation in the 
population, the urinary calcium excretions of 
stone-formers all lie within the projected range 
for the normal population, albeit within the 
upper half of that range (Robertson et al., 
1978; Bataille et al., 1983; Robertson and 
Peacock, 1985a). There is certainly not the 
clear-cut separation between the urinary calcium 
excretions of calcium stone-formers and their 
controls that exists between the cystine 
excretions of cystinuric stone-formers and their 
controls (Robertson and Peacock, 1985b). 
If the hypothesis that hypercalciuria is 
the main risk factor for calcium stone-formation 
is correct, then therapeutic measures designed 
to decrease urinary calcium excretion would be 
expected to reduce the rate of recurrence of 
calcium stone-formation in patients affected 
with the disorder. Although many of these 
modalities, such as thiazide diuretics (Yendt, 
1970; Coe and Kavalich, 1974), cellulose 
phosphate (Pak et al., 1974) and a low calcium 
diet (Nordin et al., 1973), have been claimed to 
have a benefi ci a 1 effect on stone recurrence, 
more recent reports have cast doubt on their 
efficacy. Such doubts have arisen (a) because 
of faults in the design of the studies concerned 
( Churchi 11 , 1987), ( b) because the effect of a 
particular form of treatment in long-term 
studies seems to be minimal (Marickar and Rose, 
1985), or (c) because the treatment concerned 
leads to adverse changes in urine biochemistry, 
W.G. Robertson and H. Hughes 
such as an increase in urinary oxalate or pH, 
which may more than offset the beneficial effect 
of reducing urinary calcium (Marshall and Barry, 
1973; Hall son and Rose, 1978; Hall son, 1988). 
There are growing doubts, therefore, about the 
importance of hyperca lei uri a ~ as a major 
risk factor for calcium stone-formation. This 
has led some of the former protagonists of the 
"hypercalciuria theory" to turn their attention 
to other possible urinary risk factors, such as 
hypocitraturia (Pak et al., 1985) and defective 
inhibitors of crystallization such as 
"nephrocalcin" (Coe and Parks, 1990). 
One important factor which these and many 
other workers continue to overlook, however, is 
the importance of mild hyperoxaluria in calcium 
stone-formation. Calcium oxalate, after all, is 
consistently the most common constituent of 
calcium-containing calculi in stone series 
reported from all parts of the world and mild 
hyperoxa 1 uri a should deserve at 1 east as much 
attention as hyperca 1 c i uri a as a factor in the 
formation of such calculi. 
The main problem for most potential 
researchers in this area has been the difficulty 
in measuring oxalate reliably in biological 
fluids. Unlike the situation with respect to 
the measurement of urinary calcium, the accurate 
determination of oxalate in urine has only 
become possible in recent years with the 
application of the modern techniques of high 
performance liquid chromatography (HPLC) (Hughes 
et al., 1982), ion-chromatography (Menon and 
Mahle, 1983; Robertson et al., 1982, Robertson 
and Scurr, 1984) and gas chromatography 
(Yanagawa et al., 1983). In general, however, 
urinary oxalate (where measured at all) is still 
assayed badly (Samuell, 1988), particularly when 
using techniques other than those described 
above. The reasons for the unre l i abi 1 ity of 
most methods are multifactorial but are most 
frequently due to inadequate handling and work-
up of urine prior to the actua 1 measurement, 
particularly in the case of urines which contain 
crystals of calcium oxalate. Unless great care 
is taken either to acidify the entire urine 
sample to at least pH 1.6 (Hodgkinson, 1981) or 
to shake the whole urine thoroughly in order to 
disperse the crystals homogeneously before sub-
aliquot i ng, the probability of over- or under-
estimating oxalate is extremely high. Even 
collecting the urine directly into acid is 
problematic since Stone Clinics are generally 
unwilling to put sufficient acid (at least 100 
ml of 1 molar HCl) in the container to ensure 
that the overall pH will be less than 1.6 at the 
end of the 24-hour collection. 
In those laboratories which have taken all 
the precautions necessary to ensure that the 
urine is correctly handled before oxalate is 
measured, important differences between the 
oxalate excretion of stone-formers and controls 
have been reported (Robertson et al., 1971, 
1978, 1989; Revusova et al., 1971; Baggio et 
al., 1983; Bataille et al., 1983; Pena et al., 
1987; Larsson and Tisel ius, 1987; Rose, 1987; 
Smith, 1991). However, there appears to be no 
complete separation in oxalate excretion between 
stone-formers and normals. In this respect mild 
hyperoxa l uri a does not appear to be different 
from hypercalciuria. More in-depth studies have 
shown, however, that, when stone-formers are 
studied when they first present with stones, 
their mild hyperoxaluria is much more marked 
than after they consult their urologist or 
physician (Robertson and Peacock, 1980). The 
overlap between the oxalate excretions of stone-
formers and normals when they first present is 
much less than it is when they are referred 
later to the specialist Stone Clinic. This 
reduction following hospitalization or out-
patient consultation is now a recognised feature 
of the so-called "stone clinic effect" (Hoskin 
et al., 1983; Norman et al., 1984) and should 
not be discounted in the assessment of patients 
presenting with stones. 
It would seem from the above evidence that 
hypercalciuria and mild hyperoxaluria are both 
common findings among stone-forming populations, 
so why then has doubt been cast on the 
importance of hypercalciuria in the pathogenesis 
of stones and what new evidence is there to 
support the hypothesis that mi 1 d hyperoxa l uri a 
is a much more significant risk factor than 
hypercalciuria for stone-formation? 
Relative Importance of Hypercalciuria and Mild 
Hyperoxaluria for Urolithiasis 
The relative effects of hypercalciuria and 
mild hyperoxaluria on the risk of calcium 
oxalate stone-formation were first investigated 
by Robertson and his co 11 eagues ( Robertson and 
Nordin, 1969; Robertson et al., 1971; Robertson 
and Peacock, 1980). Their initial findings in 
this respect have since been largely confirmed 
by others (Bataille et al., 1983; Hallson, 1988; 
Lindsjo, 1989). The hypothesis that mild 
hyperoxaluria is much more critical than 
hypercalciuria in the pathogenesis of calcium 
oxalate stone-formation was developed based on 
findings obtained from both in vitro and in vivo 
studies. 
In Vitro Studies 
Simple titration studies on whole urine in 
vitro indicated that it was extremely difficult 
(and in most cases impossible) to produce 
spontaneous crysta 11 i zat ion of calcium oxalate 
by the addition of a concentrated so 1 ut ion of 
calcium chloride, even up to total calcium 
concentrations in urine of 15 to 20 mmol/1 -
well outside both the normal and stone-forming 
ranges. On the other hand, it was found to be 
possible to induce spontaneous crystallization 
in almost every urine tested by the addition of 
relatively small quantities of a solution of 
sodium oxalate (Robertson and Nordin, 1969). 
Indeed, crysta"llization was found to be 
initiated spontaneously in most urines when the 
oxalate concentration reached a value of 
approximately 0.4 mmol/1 (the upper limit of 
normal). 
The chemical reason for this difference is 
shown in the lower panels of Fig. 1 which 
contain the bands of supersaturation values 
Oxalate in Urolithiasis 
measured in urine in relation to increasing the 
concentrations of calcium and oxalate 
independently. Clearly, the upper limit of 
metastability can be exceeded in only a few 
cases by increasing urinary calcium alone 
whereas it is exceeded in all urines whose 
oxalate concentrations reach the upper limit of 
normal. 
The upper panels of Fig. show the 
relative effects of independently increasing 
urinary calcium and oxalate concentration on the 
maximum volume of calcium oxalate crystals 
produced. Whereas hypercalciuria has virtually 
no influence on the volume of crystals produced, 
mild hyperoxaluria produces a marked linear 
increase in crystalluria. Only in urines with a 
very low calcium content is there a limited 
relationship between crystalluria and calcium 
concentration. 
Another chemical factor (in addition to 
supersaturation) which is important in 
determining the volume and size of calcium 
oxalate crystals and aggregates produced in a 
given solution or urine is the ratio of 
oxalate/calcium concentration. Fig. 2 shows 
that for any one of a number of defined initial 
levels of supersaturation with respect to 
calcium oxalate, the closer the oxalate/calcium 
ratio of the solution or urine is to 1: 1 the 
greater is the volume of crystals produced. 
These curves are extremely important in 
explaining why stone-forming populations in the 
Middle East have much more severe calcium 
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Fig. 1. The effect of independently increasing 
urinary calcium or oxalate concentration on the 
relative supersaturation of urine with respect 
to calcium oxalate (lower panels) and on the 
maximum achievable amount of calcium oxalate 
crystalluria (upper panels). (FP and SP 
represent the formation and solubility products 
of calcium oxalate). 
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oxalate crystalluria than stone-forming 
populations in the West in spite of the fact 
that both groups have approximately the same 
initial levels of calcium oxalate 
supersaturation in their urine (Robertson et 
al., 1989). The mean oxalate/calcium ratio in 
the urine of recurrent stone-formers in Saudi 
Arabia, for example, is 0.164 compared with 
0.054 in the urine of recurrent stone-formers in 
the UK. Both have approximately the same level 
of supersaturation [between 1.10 and 1.20 on the 
log (relative supersaturation) scale of Marshall 
and Robertson (1976)] yet the Saudi stone-
formers excrete about twice the volume of 
crystals produced by their counterparts in the 
UK. The reason why the Saudi stone-formers do 
not have very much higher supersaturation values 
than stone-formers in the UK is that their much 
higher urinary oxalate excretions are largely 
offset by their extremely low urinary excretions 
of calcium (Robertson et al., 1989). 
Fig. 2 clearly shows that an increase in 
the oxalate/calcium ratio of urine is, in fact, 
more important than an increase in the relative 
supersaturation of urine with respect to calcium 
oxalate in determining the volume of calcium 
oxalate crystals produced. This factor has been 
totally ignored by stone reseachers in the past 
and has important implications for the treatment 
of stone disease. 
In addition to influencing the volume of 
crystals produced in solution or in urine, an 
increase in the oxalate/calcium ratio of the 
medium to values closer to 1:1 markedly 
increases the average size of the crystals and 
aggregates generated (Fig. 3). This appears to 
be a function of (a) the increase in the total 
number of calcium oxalate crystals produced 
which are available for agglomeration, (b) the 
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Fig. 2. The relationship between the volume of 
calcium oxalate crystals precipitated and the 
initial oxalate/calcium ratio in solution 
derived at three different starting levels of 
supersaturation with respect to calcium oxalate. 
[Log RS CaOx is the relative supersaturation of 
urine with respect to calcium oxalate as defined 
by Marshall and Robertson (1976)]. 
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Fig. 3. The relationship between the logarithm 
of the number of calcium oxalate particles 
produced and particle diameter at three 
different initial oxalate/calcium ratios in 
solution. The starting level of supersaturation 
with respect to calcium oxalate was the same in 
each case. 
to promote crystal growth and (c) the diminution 
of the surface charge on the crystals which also 
increases the degree of agglomeration. This 
last mentioned phenomenon is due to the fact 
that, at low oxalate/calcium ratios in the 
supernatant fluid, calcium oxalate crystals have 
a net positive surface charge as a result of the 
excess of calcium over oxalate ions in the 
hydration layer surrounding the crystals 
(Curreri et al., 1979; Scurr and Robertson, 
1986). This net positive charge causes mutua 1 
repulsion between the crystals, thereby reducing 
the probability of the crystals agglomerating. 
When the oxalate/calcium ratio of the 
supernatant approaches 1:1, however, the net 
surface charge tends towards neutrality, under 
which conditions agglomeration becomes much more 
likely. 
In Vivo Studies 
In vivo studies (paralleling the above 
mentioned in vitro studies on the addition of 
calcium to urine) were carried out in which an 
oral load of calcium (in the form of calcium 
cit rate sufficient to increase urinary ca lei um 
by up to 60%) was given to stone-formers. This 
regimen failed to increase the volume of calcium 
oxalate crystals excreted by the patients 
(Robertson et al., 1969). In contrast, 
corresponding studies using an oral load of 
sodium oxalate produced marked calcium oxalate 
crystalluria in the same patients within about 2 
to 3 hours (Fig. 4). Similar results have been 
reported from studies in rats (Khan et al., 
1992). Together these in vivo findings bear out 
the predictions which would be made from Figs. 
1-3. 
A further set of studies on calcium oxalate 
crystalluria in fresh urine samples maintained 
at 37°C from recurrent, primary calcium stone-
formers showed that there are strong 
relationships between each of the following and 
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Fig. 4. The volume concentration of calcium 
oxalate crysta 1 s in fresh warm urine samp 1 es 
from a group of recurrent idiopathic calcium 
stone-formers (a) on their basal diet, (b) on 
their basal diet plus 25 mg/kg body weight of 
additional calcium (given as calcium citrate) 
and (c) on their basal diet plus 3 mg/kg body 
weight of additional oxalate (given as sodium 
oxalate). 
the concentration of oxalate in urine: (a) the 
total volume of calcium oxalate crystals 
excreted, (b) the percentage by weight of 
abnormally large crystals and aggregates of 
ca 1 c i um oxa 1 ate and ( c) the recurrence rate of 
stone-formation (Robertson and Peacock, 1980). 
There were no re 1 at i onshi ps, however, between 
the same parameters and the concentration of 
calcium in urine. These findings have 
subsequent 1 y been confirmed by Ha 11 son ( 1988) 
and Lindsjo (1989). 
The reason for the relatively weak 
relationship between the crystallization markers 
of stone disease and urinary calcium is 
complicated (Robertson and Nordin, 1969). 
Basically it is due to the combination of the 
following factors: (a) the formation of a 
strong, soluble complex between Ca2+ and CO 2-
ions and (b) the relatively high calcium/oxaiate 
ratio which prevails in most urines. As a 
consequence of this combination of factors, any 
further increase in the urinary concentration of 
ionized calcium ([Ca2+]) (which in normal urine 
is about 20 times that of ionized oxalate 
([C
2
0/l) is almost entirely offset by a 
proportional decrease in the concentration of 
ionized oxalate. Thus the product of [Ca2+] x 
[C
2
o/-l remains virtually constant over most of 
the normo- to hypercalciuric range. This 
contrasts with the effect of independently 
increasing the concentration of urinary oxalate 
which, because oxalate is present in much lower 
concentrations than calcium, does not 
significantly reduce [Ca2+] by complexation when 




2-] therefore rises almost proportionally to 
the increase in oxalate concentration in the 
urine of most individuals in the population. 
Oxalate in Urolithiasis 
Demographic Studies 
Using the overlapping distributions of 
various parameters of stone-formation measured 
in the urines of stone-formers and normal 
subjects, Robertson and his colleagues (1978, 
1981} constructed a "risk curve" for each 
parameter which allowed a probability to be 
calculated that a given individual is likely to 
be a stone-former or not. Comparison of the 
various "risk curves" showed that the two most 
important risk factors for calcium stone-
formation are a low urine volume (< 1 litre/day} 
and mild hyperoxaluria (> 0.45 mmol/day}. 
Hyperca lei uri a per se, on the other hand, was 
the weakest of the six urinary risk factors 
identified at that time as playing a significant 
role in the pathogenesis of stones. This 
finding supports the conclusion drawn by 
Marshall et al. (1975} from their studies on the 
natural history of calcium stone disease that 
there was no relationship between stone disease 
and urinary calcium excretion. 
New Evidence Supporting the Importance of Mild 
Hyperoxaluria 
Studies in the Arabian Peninsula 
Stone-formation is an extremely common 
disorder in the affluent countries of the 
Arabian Peninsula and Gulf area. Current 
estimates indicate that the life-time expectancy 
of stones in men reaching the age of 60 is about 
20% (Abdel-Halim et al., 1989; Robertson, 1993}. 
This compares with a figure of 12 to 13% in 
North America and Australasia (Sierakowski et 
al., 1978; Johnson et al., 1979}, 9 to 10% in 
Scandinavia (Ljunghall, 1978), 7 to 8% in 
Western Europe (Vahlensieck et al., 1982; 
Robertson et al., 1983} and 5 to 6% in Japan 
(Koide et al., 1986}. Interestingly, the figure 
for Japan has been rising rapidly in the past 
decade as urine composition has changed in the 
population. It has been suggested that these 
changes are due to the increasing consumption of 
animal protein in that country (lguchi et al., 
1990} . 
Studies on the urine biochemistry of stone-
formers and normal controls in the United Arab 
Emirates (Husain et al., 1979; Al-Ali et al., 
1981} and in Saudi Arabia (Robertson et al., 
1989}, where the majority of stones contain 
calcium oxalate (Barkworth et al., 1989}, have 
shown that the very high prevalence rate of 
stone-formation in that part of the world occurs 
in the almost complete absence of 
hypercalciuria. On the other hand, the urinary 
excretion of oxalate is, on average, some 50 to 
70% higher than in the corresponding populations 
in the West. This strongly supports the 
hypothesis that mild hyperoxaluria is a much 
more important risk factor than hyperca l c i uri a 
for the formation of calcium oxalate stones. 
[It is interesting to note, in passing, that the 
same arguments and type of data can be put 
forward to show that the degree of alkalinity of 
urine is a much more important risk factor for 
calcium phosphate stone-formation than is 
hypercalciuria]. Thus, for both types of 
calcium stone-formation, hypercalciuria ~
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appears to be a relatively weak risk factor for 
the disorder. 
When the data from various countries on the 
life-time expectancy of stones in men are 
compared with the average daily urinary 
excretions of calcium (Fig. 5} and oxalate (Fig. 
6} in the normal male population of each of 
these countries, there is clearly a strong 
positive relationship between stone disease and 
urinary oxa 1 ate but not between stone disease 
and urinary calcium excretion. In fact, the 
latter relationship appears to be generally 
inverse except for those countries where urinary 
oxalate does not increase as urinary calcium 
decreases. A 1 so shown in Fi gs. 5 and 6 are the 
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Fig. 5. The life-expectancy of forming stones 
in men in various countries in relation to the 
mean urinary excretion of calcium in normal men 
in the same country. Also shown are the 
corresponding data for individuals with 
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Fig. 6. The 1 ife-expectancy of forming stones 
in men in various countries in relation to the 
mean urinary excretion of oxalate in normal men 
in the same country. Also shown are the 
corresponding data for individuals with 
hereditary, enteric and jejunoileal by-pass 
(JIB} hyperoxaluria. 
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mean prevalence figures for stone disease in 
patients with enteric hyperoxaluria as a result 
of bowel disease or following jejunoileal bypass 
surgery (JIB) and in patients with primary 
(hereditary) hyperoxaluria. The data in Fig. 6 
are particularly interesting because the 
relationship betweeen the prevalence figures 
from various countries and the average urinary 
oxalate excretion in these countries appears to 
continue linearly through the data collected 
from the various well-recognised- hyperoxaluric 
groups. This suggests that the rel a Hon ship 
between the occurrence of stone disease and 
urinary oxalate is a continuum over the entire 
range of urinary oxalate excretion and that, if 
urinary oxalate in the population is high 
enough, then almost everyone will form stones. 
The implications of the relationship in 
Fig. 6 are far-reaching. Firstly, it implies 
that urinary oxalate excretion is a major, if 
not prime, determinant of stone prevalence in 
the population. Any factor which leads to an 
increase in oxalate excretion in a given 
population, whether it be a high consumption of 
oxalate, hyperabsorption of oxalate from the 
diet, or increased endogenous production of 
oxalate, will markedly increase the risk of 
calcium oxalate-containing stones in that 
population. Secondly, Fig. 6 implies that other 
urinary risk factors, such as hyperca lei uri a, 
hyperuricosuria and hypocitraturia must be 
relatively unimportant as sole risk factors for 
the disorder although they may still aggravate 
the problem if they occur in conjunction with 
mild hyperoxaluria. Thirdly, it implies that 
even if urinary inhibitors of crystallization, 
such as nephrocalcin, glycosaminoglycans, 
citrate, pyrophosphate etc are important as 
protective agents against stones under 
conditions of normal oxaluria, they must be 
capable of being overwhelmed when urinary 
oxalate is increased above normal. Presumably, 
this loss of activity is due to the marked 
increase in calcium oxalate crystalluria which 
occurs as a result of mild hyperoxaluria (Fig. 
1). As the volume of crystalluria increases, 
the crystal surface area which becomes available 
to bind inhibitors may expand to levels which 
deplete the amount of inhibitors present in the 
urine concerned. Under these conditions crystal 
growth and agglomeration may proceed at a 
relatively uninhibited rate. 
Causes of Hild Hyperoxaluria 
There are three recognised causes of mild 
hyperoxaluria in the population: (a) an 
increased dietary intake of oxalate itself, (b) 
an increased intestinal absorption of oxalate 
from the diet, and (c) an increased endogenous 
production of oxalate from ingested or 
metabolically-generated precursors. Other 
suggested causes of mild hyperoxa l uri a include 
(d) a deficiency in oxalate utilisation by 
certain gut flora and (e) a decrease in the 
tubular reabsorption (or increase in the tubular 
secretion) of oxalate. 
Increased dietary intake of oxalate 
It is generally accepted that about 5-10% 
of dietary oxalate is absorbed by the intestine 
and is excreted in the urine. This absorbed 
dietary oxalate accounts for between 15 and 30% 
of urinary oxalate. However, at greater intakes 
of oxalate (> 2 mmol/day), absorbed oxalate 
constitutes an increasing percentage of the 
urinary excretion and may reach values as high 
as 50%. This percentage may be increased to 60% 
when the high intake of oxa 1 ate is accompanied 
by a low intake of calcium (Marshall et al., 
1972) or when vitamin D supplements are given to 
increase calcium absorption (Erickson et al., 
1984). 
Over a range of intakes of oxalate, calcium 
and vitamin D there is a broad relationship 
between urinary and dietary oxalate (Fig. 7). 
It is clear, however, from the spread of the 
data that factors other than the dietary intake 
of oxalate alone must be involved in determining 
the amount of oxalate excreted in the urine. 
Increased Intestinal Absorption of Oxalate 
The relationship shown in Fig. 7 is greatly 
imp roved after account is taken of the effects 
of variation in dietary calcium and in the 
absorption of calcium on the amount of oxalate 
available for absorption in the intestine. Fig. 
8 shows a plot of urinary oxalate against a 
measure of the "free oxalate" available for 
absorption in the colon. "Free oxalate" was 
calculated by subtracting from the dietary 
intake of oxalate the amount of oxalate bound to 
the non-absorbed calcium which reaches the large 
bowel after the majority of the calcium 
absorption has taken pl ace in the small 
intestine. For an individual who is in calcium 
balance, the amount of non-absorbed calcium is 
approximately the difference between the dietary 
intake of calcium and its urinary excretion. 
The full expression for "free oxalate" is given 
by the expression: 
"Free oxalate" = 0.5 [(I 0x-Nc.-k) + 
j (Nca - Ioxl2 + 2k(Nca + lox) + k2] 
where Nc = non-absorbed portion of dietary 
a calcium and is equal to (Ic -Uc) 
in mmol/day for an individu•a1 in 
calcium balance 
dietary intake of calcium in mmol/day 
dietary intake of oxalate in mmol/day 
urinary excretion of calcium in 
mmol/day 
k is a "constant" which is a function of 
the binding between calcium and oxalate 
ions and of the volume of fluid in the 
intestine/day. When Ic and I0 are in mmol and volume is appr~ximatefy 1 litre/ 
day, k has the value 5. 
The equation then reduces to: 
"Free oxalate" = 0.5 [(I 0x-Nc.-5) + 
J(Nc.-1 0.)2 + lO(Nca + I0x) + 25] 
From Fig. 8, it is clear that once the 
amount of calcium absorbed in the intestine is 
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et al (1979); Al-Ali et al. (1981), Erickson et 
al (1984), Bataille et al. (1985), Robertson et 
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Fig. 8. Urinary oxalate excretion in relation 
to "free" dietary oxalate after allowance for 
the binding of oxalate to non-absorbed calcium 
in the intestine. Data are taken from the same 
studies as in Fig. 7 and the key is identical to 
that in Fig. 7. 
taken into account and the amount of dietary 
oxalate bound to the remaining calcium is 
calculated, the relationship between urinary 
oxa 1 ate and the actua 1 amount of "free oxa 1 ate" 
available for absorption in the large bowel is 
much tighter than that shown in Fig. 7 between 
urinary oxalate and the total dietary intake of 
oxalate. This strongly supports the hypothesis 
that the oxalate/calcium ratio in the diet and 
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the abi 1 i ty of the gut to absorb ca 1 c i um are 
dominant factors in the control of the 
absorption and subsequent urinary excretion of 
oxalate. Indeed, it may be that it is the 
stone-formers' ability to hyperabsorb calcium 
from the diet (thereby indirectly releasing more 
oxalate for absorption and excretion in the 
urine) that is more important for increasing the 
risk of stone-formation than the hypercalciuria 
with which it is more directly associated 
(Robertson and Peacock, 1980) . 
Increased Endogenous Production of Oxalate 
The mild hyperoxaluria observed in the 
majority of idiopathic calcium stone-formers 
does not appear to be caused by an increased 
basal endogenous production of oxalate since 
their fasting urinary oxalate/creatinine ratios 
and fasting plasma oxalate concentrations are 
almost identical to those of non-stone-formers 
(Robertson, 1993). There remains the 
possibility, however, that the non-fasting 
endogenous production of oxa 1 ate is increased 
and that this may partly explain the increased 
urinary oxalate in some patients. Current 
evidence suggests that a small proportion of the 
mild hyperoxaluria observed in the population 
may derive from an increased ingestion and 
partial metabolism of certain amino acids [such 
as glycine, tyrosine, tryptophan, phenylalamine 
and hydroxypro 1 i ne ( Gers ho ff and Pri en, 1960)] 
or from certain sugars [ such as 1 actose, 
sucrose, fructose, xyl itol, sorbital etc 
(Conyers et al., 1990)]. The data in Fig. 8, 
however, suggest that, at most, the contribution 
of the non-fasting endogenous production of 
oxalate to urinary oxalate must be relatively 
small in comparison to the contribution from 
available exogenous oxalate. 
Deficiency in Oxalate-Metabolising Gut Flora 
It has been suggested that the availability 
of oxa 1 ate for absorption may be influenced by 
the flora of the gut. Two bacteria (Oxalobacter 
formi genes and Pseudomonas oxa 1 it i cus), the 
former of which exists in the human intestine, 
have been shown to ut i 1 i se oxa 1 ate within the 
physiological pH range (Allison et al., 1985, 
1986; Dawson et al., 1988). The role of these 
bacteria in limiting the availability of oxalate 
for absorption in the intestine is unknown but 
it has been suggested that a deficiency of 
Oxa 1 obacter formi genes in the human intestine 
might increase the possibility of 
hyperabsorption of oxalate leading to mild 
hyperoxaluria. This hypothesis remains to be 
tested. The data in Fig. 8 suggest, however, 
that this cannot be a major source of the mild 
hyperoxaluria of stone-formers. 
Change in renal handling of oxalate 
It has been suggested by some that mild 
hyperoxaluria may be partly due to either a 
decrease in the tubular reabsorption or an 
increase in the tubular secretion of oxalate 
(Cattell et al., 1962; Senekjian and Weinman, 
1982; Borsatti, 1991). However, renal handling 
studies have been hampered by the lack of a 
W.G. Robertson and H. Hughes 
reliable method for measuring plasma oxalate. 
Current indications are that oxalate is freely 
filtered at the glomerulus but that there is no 
net reabsorption either in the proximal or 
distal tubule. On the contrary, under 
physiological conditions, only a small amount of 
oxalate appears to be reabsorbed in the proximal 
tubule but this is more than offset by secretion 
of oxalate into the lumen of the proximal 
tubule. No further transport of oxalate appears 
to take place in the distal nephron. The 
combined effect of these processes is to produce 
net secretion of oxalate into the proximal 
tubule. It has been further suggested that the 
proximal tubular eel ls of stone-formers might 
secrete more oxalate into the tubular lumen than 
the proximal tubular cells of normal subjects 
but no confirmation of this hypothesis has yet 
been published. It should be noted, however, 
that mild hyperoxa l uri a due to hypersecret ion 
can only be maintained if at least one of the 
above possible causes of mild hyperoxaluria is 
also present. Chronic hypersecretion of oxalate 
without a consistently increased supply of 
oxalate to the kidney is not possible. 
Treatment of Calcium Oxalate Urolithiasis 
The data in Figs. 1 to 8 have considerable 
implications for the treatment of ca lei um 
oxalate stone disease. Firstly, they strongly 
indicate that treatments which rely solely on 
lowering urinary calcium, either by reducing the 
dietary intake of calcium itself or by 
increasing the intake of some calcium-binding 
nutrient, such as fibre, are unlikely to produce 
any benefit to the patient since urinary oxalate 
is bound to increase under these circumstances. 
Indeed, the patient may end up in a situation 
which is likely to aggravate, rather than 
reduce, the risk of calcium oxalate stones. 
Figs. 1, 2 and 3 show that the combination of 
lowering urinary calcium and increasing urinary 
oxalate will lead (i) either to no change or to 
an increase in the supersaturation of urine with 
respect to ca lei um oxalate, (ii) to an increase 
in calcium oxalate crystalluria and (iii) to 
larger aggregates of ca lei um oxalate crystals. 
All of these changes would predictably increase, 
rather than decrease, the risk of calcium 
oxalate stones. Unless the increase in urinary 
oxalate, caused by the reduction in non-absorbed 
calcium available in the intestine, can be 
prevented by simultaneously reducing the dietary 
intake of oxalate, there can be little 
beneficial effect in reducing urinary calcium by 
itself. Indeed, a recent review of treatments 
for calcium stone disease which are based on 
reducing urinary calcium, shows that the long-
term efficacy of this approach to stone 
prevention is minimal (Marickar and Rose, 1985). 
Recently, a number of workers have turned 
their attention to a diametrically opposite 
approach to the prevention of calcium oxalate 
stones. Instead of reducing the amount of 
calcium in the intestine, these authors have 
added supplements of calcium to the diet in the 
form of calcium citrate (Harvey et al., 1985; 
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Robertson et al., 1990), calcium lactate (Ito et 
al., 1992) or calcium carbonate (Robertson et 
al., 1992). In the latter two studies potassium 
citrate was given in addition to the calcium 
supplements. The concept behind this approach 
is to bind oxalate in the intestine and thereby 
reduce both its absorption in the colon and 
subsequent appearance in urine. In support of 
this hypothesis, most of the above studies have 
shown that mild hyperoxaluria can be normalised 
by supplementation of the diet with calcium. 
Where the calcium was given in an alkaline form 
or with alkali supplements, urinary calcium 
actually fell (Ito et al., 1992; Robertson et 
al., 1992). In one of our own studies from 
Saudi Arabia, where both the circulating levels 
of the active metabolites of vitamin D 
(Woodhouse and Norton, 1982) and the intestinal 
absorption of calcium (Walker et al., 1989) are 
(paradoxically) low, the increase in urinary 
calcium in stone-formers following the 
administration of calcium supplements was 
minimal and more than offset by the marked 
decrease in urinary oxalate ( Robertson et al . , 
1990). 
This form of treatment may even be of value 
in the West, where the proportion of stone-
formers who are hyper absorbers of calcium is 
much higher than in the Middle East, because the 
fall in urinary oxalate and in the urinary 
oxalate/calcium ratio should more than offset 
the anticipated increase in urinary calcium. 
Any increase in urinary calcium in these 
i ndi vi duals may be further offset by 
administering alkaline potassium citrate along 
with the calcium supplements. By stimulating 
citrate production in the distal tubule, this 
combined therapy would provide sufficient 
citrate in the urine to complex the additional 
calcium and prevent the concentration of ionized 
calcium from increasing. The net result of 
these changes should be to decrease the 
supersaturation of urine with respect to calcium 
oxalate. The total volume and degree of 
agglomeration of calcium oxalate crystals should 
also be reduced as predicted from Figs. 1-3. 
Conclusions 
Although hypercalciuria is still considered 
by many to be the main cause of calcium stone 
disease, this review shows that there is little 
or no relationship between any of the generally 
accepted parameters of- stone-formation and the 
urinary excretion of calcium. There are, 
however, strong relationships between these same 
parameters and the urinary excretion of oxalate. 
It is concluded that persistent mild 
hyperoxa l uri a is much more important than 
hypercalciuria and other suggested risk factors 
for increasing the risk of calcium oxalate 
urolithiasis in the population. 
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Discussion with Reviewers 
Y. Nakagawa: What type and amount of crystal 
growth i nhi bi tors are present in the urine of 
the Middle Eastern stone-formers? 
Authors: So far, we have measured the 
excretions of various glycosaminoglycans, 
ribonucleic acid and nephrocalcin in the urines 
of Saudi stone- formers, Saudi normal controls 
and Western expatriate normal controls living in 
Riyadh and found no significant differences 
between the groups with respect to any of these 
macromolecular inhibitors. Nor was there any 
difference in the ~-carboxyglutamic acid content 
of the nephrocalcin extracted from the urines of 
Saudi stone-formers, Saudi normals and a sample 
of normal nephrocalcin kindly supplied by Dr. 
Nakagawa for comparison. 
M. Menon: How is "hypercalciuria" defined in 
the populations from the United Arab Emirates 
and Saudi Arabia? Is it in relation to the 
excretion of calcium in normal controls in 
Arabi a or to that of normal contra ls in the 
West? 
Authors: Basically we do not use either group 
of controls for defining "hypercalciuria", which 
is a term that we tend to use very loosely to 
refer to urines with a calcium content which 
lies in the upper section of a continuous scale 
of calcium excretion extending from the lowest 
to highest values recorded for this urinary 
constituent. The scale may be considered, 
therefore, as universal and independent of the 
environment in which urinary calcium is 
determined. We envisage it as encompassing the 
entire urinary range over which a "chemical 
curve" may be described of the effect of 
increasing calcium concentration alone on the 
risk of crystalluria and stone-formation. The 
term "hypercalciuria" is then used to refer to 
urines in the upper part of this range (>7.5 
mmol/day) over which the "chemical risk curve" 
begins to rise more sharply. Our usage of the 
term has no physiological or metabolic 
significance or implications. In relation to 
the data from the Middle East, all we are saying 
is that urinary calcium is rarely high enough~ 
itself to be a major chemical cause of the high 
stone-formation rate observed in that 
population. On the contrary, it is generally so 
low that it probably prevents more people in the 
population from forming stones than otherwise 
would be the case if urinary calcium excretion 
were higher than it is. 
M. Menon: Is the relationship shown in Fig 8 
between urinary oxalate and "free" dietary 
oxalate more pronounced in stone-formers than in 
normals? 
W.G. Robertson and H. Hughes 
Authors: No, the derived data in Fig 8 are 
calculated from studies involving both stone-
formers and normals and, although no distinction 
is shown in this paper between the data from 
stone-formers and normals, there is, in fact, no 
difference between the fraction of "free" 
oxa 1 ate absorbed by the two groups at a given 
level of "free" oxalate in the intestine. If, 
however, urinary oxalate is plotted against 
total dietary oxalate intake from the same 
studies, then the stone-formers do lie on a line 
with is slightly steeper than that of the normal 
subjects. This apparently greater absorption of 
oxalate by the stone-formers from a given intake 
of oxa 1 ate, however, is not due to an inherent 
ability of the patients to absorb a greater 
fraction of oxalate from the gut, but rather it 
is a consequence of their ability to hyperabsorb 
calcium. By absorbing a greater proportion of 
calcium from the diet, relatively more "free" 
oxalate is left in the intestine for passive 
absorption lower down the gastrointestinal 
tract. Once this is taken into account, the 
data of the calcium-hyperabsorbing patients come 
together with those of the normals into the 
relatively tight fit shown in Fig 8 since both 
groups absorb the same proportion of avail ab 1 e 
"free" oxalate probably by a passive transport 
mechanism. Overall, then, the amount of oxalate 
absorbed from the intestine (and excreted in the 
urine) is basically a function of (a) the intake 
of oxalate, (b) the intake of calcium and (c) 
the ability of the gut to absorb calcium. This 
is the essence of the equation defined in the 
paper for the calculation of "free" oxalate. 
A. Hesse: Over what range would you define "mild 
hyperoxaluria"? 
Authors: As in the case of "hypercalciuria", we 
tend to use the term "hyperoxa 1 uri a" to mean a 
urinary excretion of oxalate which is high 
enough to increase markedly the chemical risk of 
crystalluria and stone-formation. In practice, 
"mild hyperoxaluria" commences at around 0.45 
mmol/day with an "upper limit" of approximately 
0.85 mmol/day. Above that figure, one would 
suspect that there was a metabolic reason for 
the hyperoxaluria although, as shown in Fig. 6, 
the tota 1 range of urinary oxalate excretion 
appears to constitute a "chemical" continuum 
over which the risk of stone-formation goes on 
increasing irrespective of the cause of the 
hyperoxaluria. 
A. Hesse: What proportion of calcium oxalate 
stones in Saudi Arabia consisted of whewell ite 
and weddelite? 
Authors: Of the predominantly calcium oxalate 
stones, 72% consisted of calcium oxalate 
monohydrate and 28% were of calcium oxalate 
di hydrate. The latter often contained a small 
proportion of apatite (<20%) but the whewellite 
stones were usually "pure". 
A. Hesse: In your opinion, should hyper-
calciuria be treated any longer and what limit 
would you use to define it? 
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Authors: This is now a very contentious 
question. If our hypothesis is correct that 
hypercalciuria, by itself is a relatively 
unimportant risk factor for stone-formation, 
then to lower urinary calcium alone may not be 
very beneficial to the patient. The only 
exception to this situation would be if urinary 
ca lei um can be reduced to 1 ess than 4 mmo l /day 
without an accompanying increase in urinary 
oxalate (see Fig. l}. This is difficult to 
achieve in practice. Indeed, serious doubts are 
now being cast on the long-term benefits of many 
urinary calcium-reducing therapies unless they 
are known to have some other beneficial effect 
on urinary composition, such as increasing 
citrate or pyrophosphate excretion. 
The question as to what level of urinary 
calcium we would define as "hypercalciuria" is 
difficult. As mentioned in the answer to the 
question from Dr. Menon, we tend to use the term 
in a chemical rather than a biological sense. 
S.H. Khan: Would the administration of calcium 
citrate to stone patients increase their urinary 
citrate and thereby reduce the relative 
supersaturation of urine with respect to calcium 
oxalate? 
Authors: Although we had hoped that this would 
be the case, there is insufficient absorbable 
alkali in calcium citrate to stimulate citrate 
production in the renal tubules. Since, 
moreover, virtually all the administered citrate 
is metabolized, this form of treatment produces 
no increase at all in either urinary pH or 
citrate excretion. The detailed effect of 
calcium citrate supplements on urinary 
composition is the subject of a further paper 
which is in preparation. 
